//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
#Throwback 🧪 REVIEW | GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management Jens J Holst
2d
Holst reflects on the development of GLP-1-based drugs for the therapy of obesity, from early observations to remarkable results in more recent clinical trials, discussing physiological, pharmacological and clinical considerations related to their use.
dlvr.it
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management - Nature Metabolism
Nature Metabolism